Health News Roundup: Shanghai to reopen all schools Sept. 1 as lockdown fears persist; Monkeypox spread may be slowing in Canada, health official says and more
Scott Miller said that in the last round of trade negotiations between the two countries, Switzerland was not prepared to open its agricultural market for U.S. products. Idaho top court allows near-total abortion ban to take effect Idaho's top court on Friday refused to stop a Republican-backed state law criminalizing nearly all abortions from taking effect after the U.S. Supreme Court overturned the 1973 decision Roe v.
Following is a summary of current health news briefs.
Shanghai to reopen all schools Sept. 1 as lockdown fears persist
China's financial hub Shanghai said on Sunday it would reopen all schools including kindergartens, primary and middle schools on Sept. 1 after months of COVID-19 closures. The city will require all teachers and students to take nucleic acid tests for the coronavirus every day before leaving campus, the Shanghai Municipal Education Commission said.
Monkeypox spread may be slowing in Canada, health official says
There are early signs that the spread of monkeypox infections are starting to slow down in Canada, but it was "too soon to tell" whether cases had plateaued, chief public health officer Theresa Tam said on Friday. "The cases are not increasing at the speed at which they were increasing at the beginning of the outbreak and so we will just keep monitoring that trend in the next number of weeks," Tam told reporters at a briefing.
U.S. and Switzerland working on facilitating pharma trade - U.S. ambassador
The United States and Switzerland can move towards free trade between their countries with sectoral deals and they are working on facilitating business in the pharmaceutical sector, the U.S. ambassador to Switzerland told the Tages Anzeiger newspaper. Scott Miller said that in the last round of trade negotiations between the two countries, Switzerland was not prepared to open its agricultural market for U.S. products.
Idaho top court allows near-total abortion ban to take effect
Idaho's top court on Friday refused to stop a Republican-backed state law criminalizing nearly all abortions from taking effect after the U.S. Supreme Court overturned the 1973 decision Roe v. Wade that had recognized a constitutional right to the procedure. In a 3-2 ruling, the Idaho Supreme Court rejected a bid by a Planned Parenthood affiliate to prevent a ban from taking effect on Aug. 25 that the abortion provider argued would violate Idahoans' privacy and equal protection rights under the state's constitution. The measure allows for abortions only in cases of rape, incest or to prevent a pregnant woman's death.
Shanghai extends weekly COVID-19 testing requirement until end of September
China's most populous city Shanghai has extended its weekly COVID-19 test requirement and extended free testing until the end of September in a bid to keep the virus in check, authorities announced on Saturday. Citizens without a record of a nucleic acid test from within seven days will be assigned a yellow code on Shanghai's health code system, the official notice said. A yellow code restricts access to some public venues.
Polio virus found in New York City wastewater, suggesting local transmission
Health officials identified the virus that causes polio in New York City's wastewater, suggesting local transmission of the virus, state authorities said on Friday, urging unvaccinated New Yorkers to get vaccinated. "The NYC Heath Department and the New York State Department of Health have identified poliovirus in sewage in NYC, suggesting local transmission of the virus," the city's health department said in a statement on Friday.
Drugmakers' shares stabilize after Zantac litigation slump
Shares in GSK, Sanofi, Haleon and Pfizer began to recover on Friday after the companies said that nothing material had changed regarding U.S. litigation focused on heartburn drug Zantac. The companies' share prices had fallen sharply this week on investor concern about the litigation over potential cancer-causing impurities that prompted the drug's withdrawal from markets in 2019 and 2020.
Analysis-U.S. move to negotiate drug prices a rare defeat for Big Pharma
Big Pharma spent more than any other industry to lobby Congress and federal agencies this year, a Reuters analysis shows, but still suffered a major defeat after failing to stop a bill that allows the government to negotiate prices on select drugs. Despite the pharmaceutical industry's spending at least $142 million on lobbying efforts, the $430 billion Inflation Reduction Act to change climate, health and tax policies will become law. It cleared its largest hurdle last week with passage in the Senate, without any Republicans joining Democrats in voting for the bill, followed by passage by the U.S. House of Representatives on Friday.
Emergent receives FDA warning letter over quality control issues
Emergent BioSolutions Inc said on Friday it had received a warning letter from the U.S. Food and Drug Administration, citing certain deficiencies at the contract drugmaker's manufacturing facility in Baltimore, Maryland. The FDA pointed to deficiencies in cleaning and maintenance of equipment to prevent contamination of drug product and also recommended the company review its quality control process, Emergent said.
(With inputs from agencies.)